Hester Biosciences Limited (HESTERBIO.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 10.37B |
| Enterprise Value | 12.28B |
| P/E Ratio | 31.65 |
| PEG Ratio | 0.32 |
| Price/Sales Ratio | 5.42 |
| Price/Book Ratio | 4.83 |
| Enterprise/Revenue | 5.99 |
| Enterprise/EBITDA | 19.11 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.17 |
| Operating Margin | 0.2 |
AD
Management Effectiveness
| Return On Assets | 0.08 |
| Return On Equity | 0.16 |
Income Statement
| Revenue | 3.33B |
| Revenue/Share | 404.77 |
| Gross Profit | 1.69B |
| EBITDA | 866.58M |
| Net Income | 556.39M |
| Diluted EPS | 67.57 |
Balance Sheet
| Total Cash | 65.38M |
| Total Cash/Share | 7.96 |
| Total Debt | 1.95B |
| Total Debt/Equity | 0.54 |
| Current Ratio | 1.37 |
| Book Value Per Share | 447.6 |
Price History
| 52-Week Change | 14.29 |
| 52-Week High | 2,350 |
| 52-Week Low | 1,239.3 |
| Moving Average 50 Days | 1,973.56 |
| Moving Average 200 Days | 1,670.64 |
Statistics
| Average Volume | 14,218 |
| Shares Outstanding | 8.51M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 7 |
| Trailing Annual Dividend Yield | 0.33 |
| Payout Ratio | 0.11 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
